Reference
Lin CF, et al. Successful erlotinib rechallenge in an EGFR-mutant metastatic non-small cell lung cancer patient with afatinib-induced drug rash with eosinophilia and systemic symptoms: A case report. Thoracic Cancer 13: 494-496, No. 3, Feb 2022. Available from: URL: http://doi.org/10.1111/1759-7714.14276
Rights and permissions
About this article
Cite this article
Afatinib/prednisolone/steroids. Reactions Weekly 1903, 23 (2022). https://doi.org/10.1007/s40278-022-13585-z
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-022-13585-z